PL353214A1 - Podstawione 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-ony i ich zastosowanie jako inhibitorów lipazy - Google Patents

Podstawione 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-ony i ich zastosowanie jako inhibitorów lipazy

Info

Publication number
PL353214A1
PL353214A1 PL00353214A PL35321400A PL353214A1 PL 353214 A1 PL353214 A1 PL 353214A1 PL 00353214 A PL00353214 A PL 00353214A PL 35321400 A PL35321400 A PL 35321400A PL 353214 A1 PL353214 A1 PL 353214A1
Authority
PL
Poland
Prior art keywords
oxdiazol
alkoxi
ones
phenyl
substituted
Prior art date
Application number
PL00353214A
Other languages
English (en)
Other versions
PL197314B1 (pl
Inventor
Stefan Petry
Karl Schoenafinger
Guenter Mueller
Karl-Heinz Baringhaus
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of PL353214A1 publication Critical patent/PL353214A1/pl
Publication of PL197314B1 publication Critical patent/PL197314B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL353214A 1999-09-04 2000-08-22 Podstawione 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-ony, sposób ich wytwarzania oraz ich zastosowanie PL197314B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19942354A DE19942354A1 (de) 1999-09-04 1999-09-04 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
PCT/EP2000/008150 WO2001017981A1 (de) 1999-09-04 2000-08-22 Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer

Publications (2)

Publication Number Publication Date
PL353214A1 true PL353214A1 (pl) 2003-11-03
PL197314B1 PL197314B1 (pl) 2008-03-31

Family

ID=7920884

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353214A PL197314B1 (pl) 1999-09-04 2000-08-22 Podstawione 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-ony, sposób ich wytwarzania oraz ich zastosowanie

Country Status (30)

Country Link
US (1) US6596742B1 (pl)
EP (1) EP1214302B1 (pl)
JP (1) JP2003508522A (pl)
KR (1) KR100723817B1 (pl)
CN (1) CN1152024C (pl)
AR (1) AR032430A1 (pl)
AT (1) ATE253059T1 (pl)
AU (1) AU781330B2 (pl)
BR (1) BR0013765A (pl)
CA (1) CA2383731A1 (pl)
CZ (1) CZ2002772A3 (pl)
DE (2) DE19942354A1 (pl)
DK (1) DK1214302T3 (pl)
EE (1) EE04811B1 (pl)
ES (1) ES2204685T3 (pl)
HK (1) HK1048318B (pl)
HR (1) HRP20020187A2 (pl)
HU (1) HUP0202988A3 (pl)
IL (2) IL148275A0 (pl)
MX (1) MXPA02001834A (pl)
NO (1) NO323129B1 (pl)
NZ (1) NZ517551A (pl)
PL (1) PL197314B1 (pl)
PT (1) PT1214302E (pl)
RU (1) RU2265600C2 (pl)
SK (1) SK285924B6 (pl)
TR (1) TR200200553T2 (pl)
WO (1) WO2001017981A1 (pl)
YU (1) YU10402A (pl)
ZA (1) ZA200201594B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10102265C1 (de) * 2001-01-18 2002-08-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
US6900233B2 (en) 2002-02-28 2005-05-31 Aventis Pharma Deutschland Gmbh Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof
DE10208987A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxidiazol-2-one, ihre Herstellung und Verwendung in Arzneistoffen
DE10208986A1 (de) * 2002-02-28 2003-09-11 Aventis Pharma Gmbh Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase
DE10247680B4 (de) * 2002-10-12 2005-09-01 Aventis Pharma Deutschland Gmbh Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
US7208504B2 (en) 2002-10-12 2007-04-24 Sanofi-Aventis Deutschland Gmbh Bicyclic inhibitors of hormone sensitive lipase
KR20070084067A (ko) * 2004-10-13 2007-08-24 와이어쓰 Ｎ-벤젠설포닐 치환 아닐리노-피리미딘 동족체
CN101821227A (zh) * 2007-07-12 2010-09-01 德维里斯公司 激素敏感性脂酶调节剂及使用方法
WO2009084970A1 (en) * 2007-12-27 2009-07-09 Bial-Portela & Companhia, S.A. 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
TW201028406A (en) 2008-12-23 2010-08-01 Bial Portela & Ca Sa 5-O-substituted 3-N-aryl-1,3,4-oxadiazolones for medical use
US8501768B2 (en) * 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
CN114163351B (zh) * 2020-09-11 2024-01-23 江苏优嘉植物保护有限公司 噁虫酮中间体2-(2-甲氧基)苯肼甲酸甲酯合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB518042A (en) 1937-09-15 1940-02-15 Ljungstroms Angturbin Ab Improvements in elastic fluid turbines of the double rotation type
US4076824A (en) 1975-02-03 1978-02-28 Rhone-Poulenc Industries Anthelmintic oxadiazolinone derivatives
FR2299028A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Nouvea
FR2299328A1 (fr) 1975-02-03 1976-08-27 Rhone Poulenc Ind Derives de l'alcoyloxy-5 phenyl-3 oxyde azo
DK156439C (da) 1980-09-15 1990-01-22 Shell Int Research 7-substituerede 2,3-dihydrobenzofuranderivater samt pesticidpraeparater indeholdende disse og en fremgangsmaade til bekaempelse af skadelige organismer
EP0067471B1 (en) 1981-06-15 1985-11-06 Shell Internationale Researchmaatschappij B.V. 7-substituted 2,3-dihydrobenzofurans, their preparation and their use as pesticides or as chemical intermediates
JPS60115502A (ja) * 1983-11-28 1985-06-22 Mitsubishi Chem Ind Ltd 殺虫剤
US5236939A (en) 1989-09-23 1993-08-17 Bayer Aktiengesellschaft Substituted 1,3,4-oxa(thia)diazolinones process for their preparation and their use of combating endoparasites
DE3931843A1 (de) 1989-09-23 1991-04-04 Bayer Ag Substituierte 1,3,4-oxa(thia)diazolinone verfahren zu ihrer herstellung und ihre verwendung der bekaempfung von endoparasiten
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents

Also Published As

Publication number Publication date
CN1371369A (zh) 2002-09-25
HUP0202988A3 (en) 2004-12-28
AR032430A1 (es) 2003-11-12
MXPA02001834A (es) 2002-08-12
CA2383731A1 (en) 2001-03-15
SK285924B6 (sk) 2007-11-02
EP1214302B1 (de) 2003-10-29
SK3012002A3 (en) 2002-06-04
AU781330B2 (en) 2005-05-19
IL148275A0 (en) 2002-09-12
HK1048318A1 (en) 2003-03-28
JP2003508522A (ja) 2003-03-04
US6596742B1 (en) 2003-07-22
CZ2002772A3 (cs) 2002-05-15
NO20021007L (no) 2002-02-28
NZ517551A (en) 2003-10-31
ES2204685T3 (es) 2004-05-01
ATE253059T1 (de) 2003-11-15
HK1048318B (zh) 2004-12-10
KR20020024336A (ko) 2002-03-29
BR0013765A (pt) 2002-04-30
CN1152024C (zh) 2004-06-02
KR100723817B1 (ko) 2007-06-04
ZA200201594B (en) 2003-04-30
NO323129B1 (no) 2007-01-08
DE19942354A1 (de) 2001-03-08
EP1214302A1 (de) 2002-06-19
EE200200109A (et) 2003-06-16
PL197314B1 (pl) 2008-03-31
DE50004274D1 (de) 2003-12-04
PT1214302E (pt) 2004-03-31
TR200200553T2 (tr) 2002-06-21
DK1214302T3 (da) 2004-02-16
HRP20020187A2 (en) 2004-02-29
AU7411200A (en) 2001-04-10
NO20021007D0 (no) 2002-02-28
EE04811B1 (et) 2007-04-16
HUP0202988A2 (hu) 2002-12-28
RU2265600C2 (ru) 2005-12-10
WO2001017981A1 (de) 2001-03-15
IL148275A (en) 2008-08-07
YU10402A (sh) 2004-11-25

Similar Documents

Publication Publication Date Title
IL144214A0 (en) Benzoheterocycles and their use as mek inhibitors
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
GB2364059B (en) Beta-Secretase enzyme compositions and methods
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
IL190220A0 (en) Novel composition and use
GB9900416D0 (en) Inhibitors
HUP0302772A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
AU5213300A (en) 2-nh-pyridones and pyrimidones as mrs inhibitors
PL353214A1 (pl) Podstawione 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-ony i ich zastosowanie jako inhibitorów lipazy
EG22491A (en) Rest-breaking composition and use thereof
GB9924522D0 (en) Enzyme inhibitors
HUP0201729A3 (en) Inhibitors of the integrin alpha v betha 6
GB0318113D0 (en) ›-Secretase enzyme compositions and methods
ZA200109120B (en) Use of Arylalkanoylpyridazines.
AU2669201A (en) Taccalonolides and their use
SI1214302T1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
GB9911606D0 (en) Composition and use
GB9929581D0 (en) Comjpositions and their use
AU6976400A (en) 1,2,3-thiadiazoles and their use as cox-2 inhibitors
GB9923117D0 (en) Insect-paper and methods for its formation and use
EG24062A (en) Novel composition and use
SI1263745T1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
GB9907415D0 (en) Biocatalyst and its use
GB9907241D0 (en) Biocatalyst and its use

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090822